ArticleBMC chemistry2025
Novel xanthan gum hydrogels boosted with crosslinked carboxymethyl chitosan and zinc oxide nanoparticles: synthesis, characterization and biological activity evaluation.
Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Novel series of carboxymethyl chitosan (CMCs)-based hydrogels was prepared using blends of various weight ratios of CMCs and xanthan gum (XG), followed by their crosslinking utilizing trimellitic anhydride isothiocyanate (TAI) in a concentricity relied on the CMCs proportion. The weight ratios of CMCs:XG were 1:3, 1:1, and 3:1, yielding three hydrogels designated by CMCs/XG(1:3), CMCs/XG(1:1), and CMCs/XG(3:1), respectively. For comparing, CL-CMCs was fabricated by crosslinking pure CMCs utilizing TAI. The hydrogels were modified via loading different concentrations of ZnONPs into their matrices, producing CMCs/XG(1:3)/ZnONPs-3%, CMCs/XG(1:3)/ZnONPs-5%, CMCs/XG(3:1)/ZnONPs-3% and CMCs/XG(3:1)/ZnONPs-5%. The chemical, inner, and morphological structures of the hydrogels and their ZnONPs composites were affirmed using the appropriate analytical instruments. Their inhibition performance against the microbes and biofilms was ordered as: CMCs/XG(3:1)/ZnONPs-5% > CMCs/XG(3:1)/ZnONPs-3% > CMCs/XG(1:3)/ZnONPs-5% > CMCs/XG(1:3)/ZnONPs-3% > CL-CMCs > CMCs/XG(3:1) > CMCs/XG(1:1) > CMCs/XG(1:3) > CMCs. While XG doesn't possess an inhibitory performance against the inspected microbes and biofilms. The CMCs/XG(3:1)-ZnONPs-5% was more effective than Amphotericin B and Vancomycin against almost all the inspected microbial strains. It was secure on the normal human cells. So, incorporation of CL-CMCs and ZnONPs with XG in the same formulations substantially boosted the inhibition efficiency of the produced composites against microbes and biofilms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.